Author:
Shah Bijal,Chen Jenny M. H.,Wu James J.,Feng Chaoling,Zhou Lang,Park Julie E.,Hadjiivassileva Tsveta,Kerbauy Fabio R.,Wade Sally W.,Keeping Sam
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference19 articles.
1. National Cancer Institute. SEER cancer statistics review, 1975–2017. 2020. https://seer.cancer.gov/csr/1975_2017/. Accessed 20 Apr 2023.
2. Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, et al. Survival of adults with acute lymphoblastic leukemia in Germany and the United States. PLoS ONE. 2014;9(1): e85554.
3. Hoelzer D, Bassan R, Dombret H, Fielding A, Ribera JM, Buske C, et al. Acute lymphoblastic leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v69–82.
4. Paul S, Rausch CR, Nasnas PE, Kantarjian H, Jabbour EJ. Treatment of relapsed/refractory acute lymphoblastic leukemia. Clin Adv Hematol Oncol. 2019;17(3):166–75.
5. Kantarjian HM, Thomas D, Ravandi F, Faderl S, Jabbour E, Garcia-Manero G, et al. Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration. Cancer. 2010;116(24):5568–74.